CNST
Constellation Pharmaceuticals, Inc.
CNST
CNST
Delisted
CNST was delisted on the 14th of July, 2021.
134 hedge funds and large institutions have $1.46B invested in Constellation Pharmaceuticals, Inc. in 2020 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 36 increasing their positions, 42 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
14% less repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 42
41% less call options, than puts
Call options by funds: $1.55M | Put options by funds: $2.61M
Holders
134
Holding in Top 10
10
Calls
$1.55M
Puts
$2.61M
Top Buyers
| 1 | +$53.4M | |
| 2 | +$31M | |
| 3 | +$26.8M | |
| 4 |
CC
Casdin Capital
New York
|
+$23.2M |
| 5 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$21.6M |
Top Sellers
| 1 | -$52.9M | |
| 2 | -$38.2M | |
| 3 | -$25.1M | |
| 4 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$23.8M |
| 5 |
Franklin Resources
San Mateo,
California
|
-$21.9M |